Dietary supplements, Nutraceuticals, Functional foods, Health ingredients, Herbals

Headlines

ESSNA urges government to excuse sports nutrition products from anti-obesity drive

The UK Government’s restrictions on high fat, sugar and salt (HFSS) products to tackle obesity should not affect sports nutrition food products, says the European Specialist Sports Nutrition Alliance (ESSNA).

Lactoferrin market set to surpass €265 million by 2027

The global Lactoferrin market size is set to surpass €265 million (315 million USD) by 2027, thanks to its increasingly relevant links to infant nutrition, immune health, the microbiome, and skin health, according to Global Market Insights, Inc (GMI).

Content provided by BioActor

Arabinoxylan from wheat endosperm: a novel prebiotic targeting gut health and immunity

Nowadays, consumers are more health-conscious than ever and take a holistic approach to their health and wellbeing – with gut health and immunity being top of mind

Industry Movers: DSM, Chime, Danone & Evolva

April 2021 and the COVID-19 saga continues to rumble on with news of an impending third wave throughout Europe. Despite plans to restrict movement, the rules don’t appear to have affected recruitment as NutraIngredients rounds up March’s movers and shakers.

Multi-strain probiotics improve glycaemic control of patients with diabetic nephropathy – 12-week RCT

A combination of probiotic strains could improve glycaemic control when taken by patients with diabetic nephropathy, a 12-week RCT conducted in China has shown.

Content provided by Lo.Li. Pharma International

Vitamin D and EGCG: A safe, effective approach for the management of uterine fibroids

Uterine fibroids are a widespread, significant health issue. Around 50% of women of reproductive age suffer from uterine fibroids, rising to even higher percentages in older people and women of color

DSM launches personalized health tech company

Royal DSM has announced Hologram Sciences, a consumer-facing company that will create brands that target various health conditions.

As a result of GRAS process FDA has no idea of what's on market, say paper's authors

A recent paper claims FDA is in the dark as to how many new ingredients have come onto the market via the GRAS process. Only limited progress has been made in the decade since a Congressional report first raised the issue and directed the Agency to make...

Coronavirus: Your one-stop blog for food industry updates

Bringing together trusted global food industry coverage from across our universe of B2B titles to provide rolling updates and breaking news on the implications of COVID-19 for the food sector.